HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T cell response to 2',3'-cyclic nucleotide 3'-phosphodiesterase (CNPase) in multiple sclerosis patients.

Abstract
T cell responses targeting myelin antigens are possibly involved in the pathogenesis of demyelinating diseases, such as multiple sclerosis (MS). Little is known about human T cell responses to 2',3'-cyclic nucleotide 3'-phosphodiesterase (CNPase), the third most abundant myelin protein. We examined the primary peripheral T cell response to CNPase and characterized CNPase-specific CD4+ long-term T cell lines (TCL) from MS patients and healthy donors. The strongest primary responses were found in two MS patients with very active disease and were directed against CNP(343-373). We identified immunodominant epitope clusters in the regions CNP(343-373) and (356-388) that were recognized in the context of MS-associated HLA-DR2 and DR4 molecules. These data provide the immunological basis for further investigation of CNPase as a potential target self-antigen in MS.
AuthorsP A Muraro, M Kalbus, G Afshar, H F McFarland, R Martin
JournalJournal of neuroimmunology (J Neuroimmunol) Vol. 130 Issue 1-2 Pg. 233-42 (Sep 2002) ISSN: 0165-5728 [Print] Netherlands
PMID12225906 (Publication Type: Journal Article)
Chemical References
  • Antigens, Surface
  • HLA-DR Antigens
  • Myelin Proteins
  • 2',3'-Cyclic-Nucleotide Phosphodiesterases
Topics
  • 2',3'-Cyclic-Nucleotide Phosphodiesterases (immunology)
  • Adult
  • Antigens, Surface (immunology)
  • CD4-Positive T-Lymphocytes (enzymology, immunology)
  • Cell Culture Techniques (methods)
  • Cell Division (immunology)
  • Cells, Cultured
  • Female
  • HLA-DR Antigens (immunology)
  • Humans
  • Male
  • Middle Aged
  • Multiple Sclerosis (enzymology, immunology)
  • Myelin Proteins (immunology)
  • Phenotype
  • T-Lymphocytes (enzymology, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: